All Clarivate websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Keeping you up to date on recent developments in oncology, including: Rethinking dose fractionation in radiotherapy for prostate cancer; Immune system, treatment, in kidney cancer; Targeting membrane protein starves pancreatic tumors; Olive oil, not just for pasta anymore.
An international whole genome sequencing study has shown that diphtheria, an easily preventable but highly contagious potentially fatal upper respiratory tract infection by Corynebacterium diphtheriae, is evolving antimicrobial resistance, which could lead to the loss of protection that has evolved with changes in the diphtheria toxin.
Keeping you up to date on recent developments in cardiology, including: Lack of ‘moral compass’ cited as driver of increase in atherectomy in PVI; Study links hypertension to atrial fibrillation; Machine learning of limited value in predicting in-hospital AMI death.
A large-scale metabolomics study of blood samples from 11,000 people has identified common biological links among a number of chronic non-communicable diseases, opening up the possibility of countering multiple diseases simultaneously.
Keeping you up to date on recent developments in neurology, including: Study finds graphene nanoparticles have positive influence on neurons; Packaging CRISPR/Cas9 components with nano-micelles enables brain genome editing; Five-year trends of Medicare payments for neurology drugs reported; Macrophages dampen neuropathic pain.
Researchers working at the Duke University Medical Center report on a breakthrough in UTI vaccine development in the March 1, 2021, issue of the Proceedings of the National Academy of Sciences.
Keeping you up to date on recent developments in diagnostics, including: Quality of smartphone-transmitted skin images; A noninvasive test for kidney transplant rejection; Fungal culprit in Crohn’s disease.
LONDON – The largest study of its kind to date has identified new biomarkers of inflammation that are both indicators of severe COVID-19 infection and distinguish it from severe influenza.
RSS
